Treatments : Shots - Health News Here you can find out how the practice of medicine is changing. We pull together the latest research on medical tests, drugs and other therapies.
Shots - Health News

Shots

Health News From NPR

Treatments

Maryland National Guard Spc. James Truong administers a Moderna COVID-19 vaccine on May 21 in Wheaton, Maryland. People vaccinated with the Moderna vaccine likely need a booster to keep up their protection against the new omicron variant of the coronavirus. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images

Omicron evades Moderna vaccine too, study suggests, but boosters help

  • Download
  • <iframe src="https://www.npr.org/player/embed/1064202754/1064614673" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

At-home rapid COVID-19 tests, like this one from Abbott, can be difficult to find and cost-prohibitive for some families. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

Why rapid COVID tests are in short supply in the U.S.

  • Download
  • <iframe src="https://www.npr.org/player/embed/1062700278/1063171502" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

People line up outside a free COVID-19 vaccination site that opened Friday in Washington, D.C. The local health department is stepping up vaccination and booster shots as more cases of the omicron variant are being identified in the United States. Samuel Corum/Getty Images hide caption

toggle caption
Samuel Corum/Getty Images

Dr. Naresh Aggarwal talks with Jennifer Bain, who volunteered for a study of Medicago's COVID-19 vaccine, in Toronto. More than 24,000 volunteers in six countries participated. Steve Russell/Toronto Star via Getty Images hide caption

toggle caption
Steve Russell/Toronto Star via Getty Images

A COVID vaccine grown in plants measures up

  • Download
  • <iframe src="https://www.npr.org/player/embed/1062152532/1062178657" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid. Stew Milne/AP hide caption

toggle caption
Stew Milne/AP

How Pfizer developed a COVID pill in record time

  • Download
  • <iframe src="https://www.npr.org/player/embed/1061060446/1061150284" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Researchers at the University of Washington Medicine Retrovirology Lab at Harborview Medical Center in Seattle process samples from Novavax's phase 3 COVID-19 vaccine clinical trial in February 2021. Karen Ducey/Getty Images hide caption

toggle caption
Karen Ducey/Getty Images

A different kind of COVID vaccine is about ready to roll

  • Download
  • <iframe src="https://www.npr.org/player/embed/1060141850/1060551920" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds. Seth Wenig/AP hide caption

toggle caption
Seth Wenig/AP

A COVID-19 antiviral pill called molnupiravir from Merck and Ridgeback Biotherapeutics is being considered by the Food and Drug Administration for emergency use in the coronavirus pandemic. Merck & Co Inc./Handout via Reuters hide caption

toggle caption
Merck & Co Inc./Handout via Reuters

Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck hide caption

toggle caption
Merck

New antiviral drugs are coming for COVID. Here's what you need to know

  • Download
  • <iframe src="https://www.npr.org/player/embed/1059926089/1060212486" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Danyelle Clark-Gutierrez and her service dog, Lisa, shop for food at a grocery store. Clark-Gutierrez got the yellow Labrador retriever to help her cope with post-traumatic stress disorder after she experienced military sexual trauma while serving in the Air Force. Stephanie O'Neill for KHN hide caption

toggle caption
Stephanie O'Neill for KHN

More veterans with PTSD will soon get help from service dogs. Thank the 'PAWS' Act

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045708726/1061354875" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Eugene Mymrin/Getty Images

New clues to the biology of long COVID are starting to emerge

  • Download
  • <iframe src="https://www.npr.org/player/embed/1053509795/1056761978" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Amyloid plaques are characteristic features of Alzheimer's disease. The new drug Aduhelm is able to remove this sticky substance that builds up in the brains of patients with the disease, but many doctors are still skeptical of how well it really works. Kateryna Kon/Science Photo Libra via Getty Images hide caption

toggle caption
Kateryna Kon/Science Photo Libra via Getty Images

Cost and controversy are limiting use of new Alzheimer's drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1052833252/1054175455" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A hormone-blocking drug implant was prescribed for an active 8-year-old girl diagnosed with central precocious puberty. The price of one option was thousands of dollars less than the other. Kristina Barker for KHN hide caption

toggle caption
Kristina Barker for KHN

Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one

  • Download
  • <iframe src="https://www.npr.org/player/embed/1051878026/1053528002" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Researchers are studying athletes and military personnel to learn more about how a concussion can affect the brain's ability to understand sound. Callista Images/Image Source/Getty Images hide caption

toggle caption
Callista Images/Image Source/Getty Images

After a concussion, the brain may no longer make sense of sounds

  • <iframe src="https://www.npr.org/player/embed/1052508809/1052785140" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A box and container of ivermectin arranged in Jakarta, Indonesia, on Thursday, Sept. 2, 2021. The U.S. Food and Drug Administration warned Americans against taking ivermectin, an anti-parasitic drug, as treatment or prevention against Covid-19. Dimas Ardian/Bloomberg via Getty Images hide caption

toggle caption
Dimas Ardian/Bloomberg via Getty Images

Ari Blank got a comforting hand-squeeze from his mom in May as he was vaccinated against COVID-19 in Bloomfield Hills, Mich. This week, the Food and Drug Administration authorized the use of Pfizer's vaccine in even younger kids — ages 5 to 11. Jeff Kowalsky/AFP via Getty Images hide caption

toggle caption
Jeff Kowalsky/AFP via Getty Images

A nurse draw a Moderna COVID-19 vaccine dose from a vial at the Cameron Grove Community Center in Bowie, Md., in late March. Moderna says study data supports use of a half-dose of the vaccine in children 6 to 11. Win McNamee/Getty Images hide caption

toggle caption
Win McNamee/Getty Images

Pharmacist LaChandra McGowan prepares a dose of the Pfizer COVID-19 vaccine at a clinic operated by DePaul Community Health in New Orleans in August. Soon, children ages 5 to 11 could be eligible for Pfizer shots. Mario Tama/Getty Images hide caption

toggle caption
Mario Tama/Getty Images

A health care worker prepares a dose of the Moderna COVID-19 vaccine during a clinic held at the Watts Juneteenth Street Fair in the Watts neighborhood of Los Angeles. Patrick T. Fallon/AFP via Getty Images hide caption

toggle caption
Patrick T. Fallon/AFP via Getty Images

Nurse Christina Garibay administers Johnson & Johnson's COVID-19 vaccine to a man at a community outreach event in Los Angeles in August. Frederic J. Brown/AFP via Getty Images hide caption

toggle caption
Frederic J. Brown/AFP via Getty Images
Shots - Health News

Shots

Health News From NPR

About